Published in Horm Res on January 01, 1992
High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child (2002) 1.06
In children with idiopathic short stature, what advantage does administering recombinant growth hormone have over observation in final adult height?: Part A: Evidence-based answer and summary. Paediatr Child Health (2003) 0.75
Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol (2008) 1.99
Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr (1993) 1.94
A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes (1997) 1.86
Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet (1996) 1.76
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia (2012) 1.60
Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab (1995) 1.27
Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene. Nat Genet (1994) 1.18
Diazepam in the treatment of strychnine poisoning. Case report. Br J Anaesth (1972) 1.16
Nephrogenic diabetes insipidus, cystinosis, and vitamin D. Arch Dis Child (1988) 1.10
Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone. Br J Haematol (2008) 1.06
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) (1978) 1.04
Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. Eur J Endocrinol (2007) 1.02
Persistent hyperinsulinaemic hypoglycaemia of infancy: long-term treatment with the somatostatin analogue Sandostatin. Clin Endocrinol (Oxf) (1989) 0.99
Regulation of insulin release in persistent hyperinsulinaemic hypoglycaemia of infancy studied in long-term culture of pancreatic tissue. Diabetologia (1990) 0.99
Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes (1999) 0.96
Reproducibility of growth hormone testing procedures: a comparison between 24-hour integrated concentration and pharmacological stimulation. J Clin Endocrinol Metab (1990) 0.94
Diminished prolactin reserve: a case report. J Clin Endocrinol Metab (1977) 0.94
Recombinant mapping of the familial hyperinsulinism gene to an 0.8 cM region on chromosome 11p15.1 and demonstration of a founder effect in Ashkenazi Jews. Hum Mol Genet (1995) 0.90
Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients' monitoring after transplantation. Bone Marrow Transplant (2012) 0.89
Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism. Hum Mutat (1999) 0.89
Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center. Bone Marrow Transplant (2013) 0.88
Persistent hyperinsulinemic hypoglycemia of infancy ("nesidioblastosis"): autosomal recessive inheritance in 7 pedigrees. Am J Med Genet (1990) 0.87
Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. J Clin Endocrinol Metab (1990) 0.86
Light-chain amyloidosis: SCT, novel agents and beyond. Bone Marrow Transplant (2012) 0.86
Precocious puberty in myelomeningocele patients. J Pediatr Orthop (1984) 0.85
Neonatal hyperinsulinism--surgical and pathologic considerations. J Pediatr Surg (1980) 0.85
Persistent neonatal hypoglycemia due to hyperinsulinism: medical aspects. Pediatrics (1982) 0.85
Periodontal disease in patients with ankylosing spondylitis. Ann Rheum Dis (2010) 0.85
Healing of dentate or edentulous mandibular fractures treated with rigid or semirigid plate fixation--an experimental study in dogs. J Craniomaxillofac Surg (1996) 0.84
11-deoxycortisol in amniotic fluid: prenatal diagnosis of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Clin Endocrinol (Oxf) (1980) 0.83
Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance. Leukemia (2013) 0.83
Adrenocortical reserve of neonates born of long-term, steroid-treated mothers. Eur J Pediatr (1984) 0.82
Clinical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Horm Res (1982) 0.81
Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency. J Pediatr (1994) 0.81
Age-related patterns of thyroid-stimulating hormone response to thyrotropin-releasing hormone stimulation in Down syndrome. Am J Dis Child (1991) 0.80
TSH secretion in thalassemia. J Endocrinol Invest (1984) 0.79
The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission--a preliminary report. J Pediatr Endocrinol (1993) 0.79
Renal tubular acidosis in a patient with hypothyroidism due to autoimmune thyroiditis - improvement with hormone replacement therapy. Int J Pediatr Nephrol (1982) 0.79
No linkage between HLA and congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. N Engl J Med (1979) 0.78
Vitamin D-dependent rickets types I and II. Diagnosis and response to therapy. Isr J Med Sci (1985) 0.78
The definition of a spontaneous growth hormone (GH) peak: studies in normally growing and GH-deficient children. J Clin Endocrinol Metab (1992) 0.78
Age and seasonal factors in the incidence of premature sexual development in girls in the Jerusalem area. Clin Invest Med (1989) 0.77
[Osteo-odonto-keratoprosthesis. A summary of 6 years surgical experience]. Ophthalmologe (2002) 0.77
[Dental and orthodontics findings in patients with mucopolysaccharidosis]. Fortschr Kieferorthop (1988) 0.77
Amniotic fluid 3,3',5'-triiodothyronine in the detection of congenital hypothyroidism. J Clin Endocrinol Metab (1980) 0.77
Final height after growth hormone therapy in short children: correlation with siblings' height. Horm Res (1997) 0.76
Parathyroid adenoma after radiation in an 8-year-old boy. J Pediatr (1998) 0.76
Cushing's disease presenting as pubertal arrest. J Pediatr Endocrinol (1993) 0.76
Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation. J Clin Endocrinol Metab (1992) 0.76
Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: gender reassignment in early infancy. Acta Endocrinol (Copenh) (1986) 0.76
Improvement of the osteo-odonto-keratoprosthesis according to Strampelli: influence of diameter of PMMA cylinder on visual field. Graefes Arch Clin Exp Ophthalmol (1999) 0.75
Cancer-testis antigen expression and immunogenicity in AL amyloidosis. Blood Cancer J (2012) 0.75
Predictors of growth response to growth hormone in otherwise normal short children. J Pediatr (1992) 0.75
Pituitary insufficiency following head injury. Isr J Med Sci (1978) 0.75
11 beta-Hydroxydehydroepiandrosterone in a case of virilizing adrenal adenoma: isolation from urine and mitochondrial conversion from dehydroepiandrosterone. J Clin Endocrinol Metab (1978) 0.75
Growth and sexual development before and after sex steroid therapy in patients with thalassemia major. Arch Intern Med (1984) 0.75
[The induction of experimental fractures in the mandibles of dogs]. Dtsch Z Mund Kiefer Gesichtschir (1988) 0.75
Prolactin responsiveness to TRH and metoclopramide in thalassaemia. Clin Endocrinol (Oxf) (1982) 0.75
Pituitary enlargement secondary to hypothyroidism associated with sublingual thyroid gland. Isr J Med Sci (1979) 0.75
Salt conservation in familial dysautonomia (Riley-Day syndrome). Isr J Med Sci (1977) 0.75
[Diagnostic problems in nodular fasciitis of the face and neck]. Dtsch Z Mund Kiefer Gesichtschir (1989) 0.75
Raw cornstarch as an additional therapy in nesidioblastosis. Am J Clin Nutr (1988) 0.75
[Neonatal hyperinsulinism]. Harefuah (1980) 0.75
The diagnostic value of integrated growth hormone secretion studies shorter than 24 hours in normal- and short-growing children. Horm Res (1992) 0.75
[Results of study on a change in the treatment of odontogenic maxillary sinusitis in the presence of an oro-antral opening]. Dtsch Zahnarztl Z (1988) 0.75
Histological findings in the alveolar sockets and tooth roots after experimental mandibular fractures in dogs. J Craniomaxillofac Surg (1997) 0.75
Celiac disease and short stature--not always cause and effect. J Pediatr Endocrinol Metab (2001) 0.75
An uncommon cause of high serum protein-bound iodine. Isr J Med Sci (1972) 0.75
Detection of albumin binding abnormalities in sera of patients with familial dysalbuminaemic hyperthyroxinaemia using isoelectric focusing. Endocr Res (1992) 0.75
Thyroid function tests in the first year of life. Isr J Med Sci (1973) 0.75
Disaccharidase activities in the rat intestine. II. Effect of progesterone. Am J Clin Nutr (1974) 0.75
Combined treatment of severe hyponatremia due to inappropriate antidiuretic hormone secretion. Pediatrics (1982) 0.75
Chronic growth hormone administration does not suppress endogenous growth hormone secretion in patients with neurosecretory growth hormone dysfunction. Horm Res (1991) 0.75
Short stature: new challenges in growth hormone therapy. J Pediatr Endocrinol (1994) 0.75
Hypothalamic-pituitary axis in total lipodystrophy. Monogr Hum Genet (1978) 0.75
Normal proinsulin processing despite beta-cell dysfunction in persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis). Diabetologia (1996) 0.75
Effect of growth hormone therapy on IGF-I, bone GLA-protein and bone mineral content in short children with and without chronic renal failure. Horm Res (1992) 0.75
Vasoactive intestinal peptide-secreting tumor appearing as growth failure. Am J Dis Child (1983) 0.75
[Experimental studies on the behavior of a non-soluble collagen preparation after subperiosteal implantation in canine mandibles]. Dtsch Zahnarztl Z (1988) 0.75
A comparison of symptom evaluations by psychiatrists and social workers. Hosp Community Psychiatry (1972) 0.75
Age as a determinant of the impact of growth hormone therapy on predicted adult height. Clin Endocrinol (Oxf) (1994) 0.75
The effect of exogenous and endogenous growth hormone on plasma growth hormone binding activity in prepubertal children. Horm Res (1993) 0.75
Plasma renin activity and aldosterone in familial dysautonomia. Metabolism (1974) 0.75